DEA Proposed Rule Seeks to Reclassify Marijuana

In his latest article for Pharmacy Times, Ned Milenkovich discussed recently proposed rules from the U.S. Department of Justice to reclassify marijuana under the Controlled Substances Act. Ned, chair of Much’s Health Care group, explained how this potential reclassification could impact the manufacture, distribution, dispensing, and possession of marijuana, as well as the role pharmacists could play in counseling patients about cannabis products.